USPTO serial 79114549
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
FR
F-68200 Mulhouse, FR
F-68200 Mulhouse, FR
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan Myers
JONATHAN MYERS KF ROSS, P.C.5720 MOSHOLU AVE.P.O. BOX 900BRONX, NY 10471-0900| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations intended for use in cell cultures; Cell culture media for cultivating stem cells; Growth media for cell growth, namely, culture media for cultivating stem cells intended for medical biotechnology; Biological reagents for molecular biology, chemical reagents for medical use for biological methods; Growth media adapted for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; Cellular function activating agents, namely, cell growth factors and hematopoietic factors; Medicated serums, namely, human serums for cell culture; Antibodies, namely, monoclonal antibodies for the selection and purification of stem cells; All of the aforementioned goods being for medical use | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus and instruments for use in cellular therapy, medical apparatus for cell cultivation, medical instruments for cell cultivation, medical apparatus and devices intended for cell separation techniques | SECTION 71 - CANCELLED | — |
| 042 | Research and development of new products in the field of biotechnology, scientific analysis for medical purposes and the development of new products for medical research for thirds parties | SECTION 71 - CANCELLED | — |
| 044 | Medical care and treatment; Medical services, namely, cell collection, isolation and growth services for medical purposes; Medical analysis in connection with the treatment of individuals, namely, in vitro diagnostic, testing and statistic analysis of the patient status for medical purposes; Therapeutic treatments | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 26, 2022 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 26, 2022 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 31, 2022 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Aug 24, 2022 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jul 4, 2022 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 3, 2022 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 29, 2022 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jun 29, 2022 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 25, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 28, 2020 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 4, 2020 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Nov 3, 2020 | INPC | INVALIDATION PROCESSED | — |
| Oct 14, 2020 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 14, 2020 | C71T | CANCELLED SECTION 71 | — |
| Feb 6, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 22, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 1, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 9, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 2, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 10, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 10, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 9, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 9, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 22, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 23, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 23, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 3, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 3, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 3, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 19, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 12, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 12, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 4, 2013 | ALIE | ASSIGNED TO LIE | — |
| Mar 1, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2012 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 5, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 4, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 31, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 30, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 28, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 24, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 20, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 19, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |